EUA
INDICAID COVID-19 IgM/IgG Rapid Test
FDA Emergency Use Authorization · Jiangsu Well Biotech Co., Ltd. · Mar 1, 2022
Key facts
| Product | INDICAID COVID-19 IgM/IgG Rapid Test |
|---|---|
| Company | Jiangsu Well Biotech Co., Ltd. |
| Product type | IgM and IgG, Lateral Flow |
| Date | Mar 1, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: